Shweta Maniar, global strategy and market leader for life sciences at Google Cloud, sits down with Nagaraja Srivatsan to unpack what it takes to turn AI pilots into durable, enterprise-wide impact. A former biotech executive who now helps biopharma leaders modernize their data and AI strategy, Shweta argues that success starts with fixing fragmented data foundations and reshaping culture—not just deploying the latest model. She explains why AI should be treated as a strategic upgrade to de-risk science rather than a narrow tool for squeezing efficiency, why the hardest problems are less about model performance and more about data and organizational behavior, and how emerging multi-agent systems could compress timelines from discovery to patient access. You can download The ROI of AI in Healthcare and Life Sciences report referenced in the discussion here: https://cloud.google.com/resources/content/roi-of-ai-healthcare-life-sciences
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Finding ROI from AI in the Mundane
A Pragmatic Path to AI-Enabled Commercial Operations
Orchestrating Scientists, Data, and AI to Discover New Drugs
Scaling Practical AI Across Commercial Teams
Free AI-powered recaps of Life Sciences DNA Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.